Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin conjugating enzyme E2 D3 pseudogene 1 (UBE2D3P1)
- Target
- UBE2D3P1
- Molecular classification
- Pseudogene (more specifically, protein-coding gene duplicate rendered nonfunctional), Other (not an enzyme, not a receptor, etc.)
01
Overview
UBE2D3P1 (Ubiquitin conjugating enzyme E2 D3 pseudogene 1) is a non-functional pseudogene located in the human genome, resembling the gene structure of UBE2D3—a member of the ubiquitin-conjugating enzyme E2 family. Unlike its parental counterparts, UBE2D3P1 does not encode a protein and has no enzymatic activity. Pseudogenes generally arise from duplication or mutation events rendering them transcriptionally inactive or unable to form functional protein products. There is currently no evidence that UBE2D3P1 is involved in any regulatory RNA function or associated with human diseases. It should not be mistaken for UBE2D3, an active ubiquitin-conjugating enzyme involved in key signaling, protein turnover, and pathways regulating cell cycle and apoptosis.
- Other names
- RP4-680N4UBE2D3P1
02
Mechanism of action
None. No mechanism of action for drugs, as it is not a protein target.
03
Biological functions
As a pseudogene, UBE2D3P1 does not perform any canonical biological functions. Pseudogenes typically do not code for a functional protein and are generally considered non-functional at the protein level. However, it is worth noting that some pseudogenes can have regulatory roles at the RNA level, such as affecting gene expression through non-coding RNA mechanisms (ceRNA), but no evidence for such function is reported for UBE2D3P1 specifically.
04
Disease associations
None specific to UBE2D3P1 as a pseudogene. No reported involvement in diseases such as cancer, inflammation, neurodegenerative disease, etc.
Beyond the preview
Go deeper on Ubiquitin conjugating enzyme E2 D3 pseudogene 1 (UBE2D3P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ubiquitin conjugating enzyme E2 D3 pseudogene 1 (UBE2D3P1).